Track the 한국비엔씨 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 한국비엔씨 has logged 42 insider filings. The latest transaction was disclosed on 13 July 2026 (Other). Among the most active insiders: 최완규. Every trade is openly available.
42
Insider Decl.
0
Thresholds
·
7 ops.
Buy Volume
·
0 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
한국비엔씨 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and commercialization of pharmaceutical products.